Outcomes after Major Adverse Cardiovascular Events in Obese versus Non-obese MASLD Patients: A Nationwide Inpatient Sample Study

Authors

Prince A. Ameyaw, Internal Medicine, Bridgeport Hospital/Yale New Haven Health, Bridgeport, USA.
Sarpong Boateng, Internal Medicine, Bridgeport Hospital/Yale New Haven Health, Bridgeport, USA.
Tawanda Zinyandu, Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, Connecticut, USA.
Basile Njei, Department of Medicine, Section of Digestive Diseases, Yale University School of Medicine, West Haven, CT, USA.
Ashraf Ahmed, Yale New Haven Health - Bridgeport Hospital Department of Internal Medicine, Bridgeport, CT 06610, United States.

Document Type

Conference Proceeding

Abstract

MASLD is the most common etiology of chronic liver disease globally. MASLD is strongly associated with obesity and adverse cardiovascular outcomes. This study aims to investigate the outcomes after MACE in patients with obese versus non-obese MASLD.

Publication Date

Fall 2024

Recommended Citation

Ameyaw, Prince A.; Boateng, Sarpong; Zinyandu, Tawanda; Njei, Basile; and Ahmed, Ashraf, "Outcomes after Major Adverse Cardiovascular Events in Obese versus Non-obese MASLD Patients: A Nationwide Inpatient Sample Study" (2024). Posters. 39.
https://scholar.bridgeporthospital.org/poster_presentations/39